Docoh
Loading...

APYX Apyx Medical

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Company profile

Ticker
APYX
Exchange
CEO
Charles Goodwin
Employees
Incorporated
Location
Fiscal year end
Former names
AN CON GENETICS INC, BOVIE MEDICAL CORP, BOVIE MEDICAL Corp
SEC CIK
IRS number
112644611

APYX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

12 May 21
17 Jun 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 39.54M 39.54M 39.54M 39.54M 39.54M 39.54M
Cash burn (monthly) 792K 986.75K 1.61M 1.46M 684K 892.58K
Cash used (since last report) 2.03M 2.53M 4.13M 3.74M 1.75M 2.29M
Cash remaining 37.51M 37.01M 35.41M 35.8M 37.79M 37.25M
Runway (months of cash) 47.4 37.5 22.0 24.5 55.2 41.7

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 Mar 21 Waldman Lawrence Common Stock Option exercise Aquire M No No 2.81 5,563 15.63K 5,563
8 Mar 21 Waldman Lawrence Stock Option (Option to Buy) Common Stock Dispose X No No 2.81 7,500 21.08K 0
5 Mar 21 Michael Geraghty Common Stock Option exercise Aquire M No No 2.81 7,500 21.08K 7,500
5 Mar 21 Michael Geraghty Stock Option (Option to Buy) Common Stock Dispose X No No 2.81 7,500 21.08K 0
29 Jan 21 Tara Semb Stock Option (Option to Buy) Common Stock Grant Aquire A No No 9.29 48,000 445.92K 48,000
29 Jan 21 Goodwin Charles D. II Common Stock Common Stock Grant Aquire A No No 9.29 121,500 1.13M 121,500
29 Jan 21 Todd Hornsby Stock Option (Option to Buy) Common Stock Grant Aquire A No No 9.29 50,000 464.5K 50,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change

Financial report summary

?
Competition
MedtronicConmedMedtronicInmode
Management Discussion
  • Total revenue increased by 72.9%, or approximately $3.6 million, for the three months ended March 31, 2021 when compared with the three months ended March 31, 2020. Advanced Energy segment sales increased 92.2%, or approximately $3.7 million, for the three months ended March 31, 2021 when compared with the three months ended March 31, 2020. In the first quarter of 2021, we saw increased global demand for both our handpieces and generators. While demand for generators in certain geographic regions continues to be affected by the impacts of the COVID-19 pandemic, we experienced strong sales volumes overall during the first quarter.
  • International sales represented approximately 35.6% and 27.6% of total revenues for the three months ended March 31, 2021 and 2020, respectively. Management estimates our products have been sold in more than 55 countries through local dealers coordinated by sales and marketing personnel through our facilities in Clearwater, Florida and Sofia, Bulgaria.
  • Gross profit for the three months ended March 31, 2021, increased 96.4% to $5.9 million, compared to $3.0 million for the same period in the prior year. Gross margin for the three months ended March 31, 2021, was 67.8%, compared to 59.7% for the same period in 2020. The increase in profit margins for the three months ended March 31, 2021 from the prior year period is primarily attributable to sales mix between our two segments, with our Advanced Energy segment comprising a higher percentage of total sales, as well as product mix within our Advanced Energy segment as a result of our continued manufacturing efficiency initiatives and the introduction of newer product models.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: accurately, assessment, automated, cautiously, challenging, chapter, check, complying, comprised, comprising, confidence, consumer, Delaware, ease, electronically, emerge, emerging, Employer, enterprise, Equity, ERP, extended, fee, filer, FL, flow, Identification, incorporated, incorporation, Interactive, introduction, jurisdiction, mark, Mine, modified, optimistic, par, permanently, pose, preceding, Qualitative, Quantitative, recall, Regulation, rely, replaced, resource, Road, section, Senior, shell, shorter, sluggish, Strike, Title, toe, type, Ulmerton, uneven, Unregistered, Washington, wholly
Removed: accrue, accuracy, acquired, actively, adherence, adjusted, Administration, alleging, amendment, American, application, appointed, approved, approving, assigning, assist, audited, authorization, back, BDO, behalf, Bulgarian, burdensome, cancel, chain, charge, choose, Codification, collect, collection, committed, Committee, comparing, complaint, complex, complexity, compliance, compute, consistent, context, Controller, counsel, court, created, curtailed, curtailment, decline, deeper, defer, deferral, deficiency, degree, delay, delayed, denominated, dermal, design, designing, detect, detected, deteriorate, developing, disposable, disruption, District, document, documentation, domestically, Drug, economy, engineer, enhanced, enhancing, epidemic, estimation, European, evidence, executing, exempt, expeditiously, expose, extension, external, facility, failure, fairly, FDA, February, finance, firm, Food, footnote, forfeiture, framework, fully, furlough, geographical, goodwill, Goodwin, granting, greater, immaterial, implied, inadequate, ineffective, Integrated, internationally, January, July, knowledge, lack, Latin, lattice, lead, lifted, limited, LLP, member, Middle, mitigate, motion, multiple, network, North, noted, Notification, outlined, oversight, pay, payroll, perform, performed, plaintiff, planned, portion, positive, Premarket, present, President, prevented, processing, procure, production, program, purpose, putative, qualified, receive, recently, recruit, redirect, reduction, refund, released, reliability, reliable, remediate, remediated, remediating, remit, resolving, responsible, resulted, resurfacing, resurgence, retrospective, revising, sale, scale, scope, selection, September, set, shut, Simplifying, slowdown, Sponsoring, submission, Subsequent, temporarily, test, thereunder, train, Treadway, trinomial, unable, undergo, underlying, unit, USA, validating, variability, variance, vendor, verifying, volume, voluntarily